The Ministry of health denied the risk of increased drug prices due to the introduction of IT systems procurement
The assertion that the introduction of information-analytical system (IAS) for the procurement of drugs may lead to higher prices, is not true, reported the press service of the Ministry of health.
On the eve of the Deputy head of Department for control over social sphere and trade FAS of Russia Nadezhda Sharovskaya said that “now the medication information in the state register of medicines, which is the basis of the system of IAS, not uniform, contains numerous technical errors, and dosage forms and dosages are not grouped in the equivalent group.”
“Thus, without the preliminary work of the Ministry of health of Russia for the equivalence of drugs in the catalogue of medicines, which will be used by customers using the IAS system can not only significantly distort the calculation of reference prices, but also lead to reduced competition in the auction and increase of budget expenditures on procurement of medicines,” said Sharavsky.
The Ministry of health noted that “as of November 1, 2017 unified 99.5% of records in a single reference classification of drugs”.
“By the time of commercial operation of information-analytical system from 1 January 2018 all state and municipal customers will have the opportunity to make information about the contracts for the purchase of medicinal products in a structured form using unified in a common reference classification of drugs”, — noted in the Ministry of health.
The Ministry of health in conjunction with Rostec, has developed and put into trial operation of information-analytical system of monitoring and control in the sphere of state and municipal procurement of drugs on behalf of the President of Russia Vladimir Putin.